Doxorubicin liposome (HighField Biopharmaceuticals)
多柔比星脂质体 (杭州高田生物医药)
Report date: 2026/04/08 20:02:35
Base Information
Drug NameDoxorubicin liposome (HighField Biopharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHighField Biopharmaceuticals Inc
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A